Top Markets
#1 0G 0G +40.59%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.85%
#3 StonkBroker StonkBroker +33.99%
#4 Useless Coin Useless Coin +33.54%
#5 SAFEcoin SAFEcoin +28.88%
#6 Dogs Dogs +23.94%
#7 rsERG rsERG +22.27%
#8 Pons Pons +22.22%
#9 ICON ICON +22.10%
#10 Zora Zora +21.17%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Beijing Leadman Biochemistry Co.,Ltd. Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd.

300289
Classifica tra le azioni #13633
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's... Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
Prezzo delle azioni
$0.87093245
Capitalizzazione di mercato
$473.80M
Variazione (1 giorno)
-1.48%
Variazione (1 anno)
-24.54%
Paese
CN
Scambia Beijing Leadman Biochemistry Co.,Ltd. (300289)

Categoria

Healthcare
Utile per Beijing Leadman Biochemistry Co.,Ltd. (300289)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Beijing Leadman Biochemistry Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Beijing Leadman Biochemistry Co.,Ltd. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US